Fluid Biomed, a clinical-stage medical device company specializing in vascular disease treatments, has announced the successful closure of a USD $27 million Series A equity financing round. The oversubscribed round was co-led by Amplitude Ventures and an undisclosed strategic partner, with additional investment from IAG Capital Partners, LifeArc Ventures, and returning backers ShangBay Capital and […]
Calgary.Tech